Search Results

AP26113 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

AP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).

More Information Supplier Page

AP26113 25mg 25mg  | Purity Not Available

Adooq Bioscience

AP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).

More Information Supplier Page

Zotarolimus 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.

More Information Supplier Page

Zotarolimus 10mg 10mg  | Purity Not Available

Adooq Bioscience

Zotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.

More Information Supplier Page

AG-17 500mg 500mg  | Purity Not Available

Adooq Bioscience

AG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.

More Information Supplier Page

AG-17 50mg 50mg  | Purity Not Available

Adooq Bioscience

AG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.

More Information Supplier Page

AG-17 200mg 200mg  | Purity Not Available

Adooq Bioscience

AG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.

More Information Supplier Page